文献速递肾移植

美国 deceased donor 肾移植虚拟交叉配型的应用趋势及其对冷缺血时间与临床结局的影响

Trends and impact on cold ischemia time and clinical outcomes using virtual crossmatch for deceased donor kidney transplantation in the United States.
PubMed 文献 · Kidney Int · 2021-04-30

该回顾性队列研究基于美国移植受者科学登记数据,纳入2011–2018年成人 deceased donor 肾移植受者,其中9,632例采用虚拟交叉配型、71,839例采用物理交叉配型。2014年分配政策变更后,虚拟交叉配型使用率每年增加2.4%,2018年达18%;与物理交叉配型相比,虚拟交叉配型与更短冷缺血时间相关(平均15.0 vs 16.5小时),死亡删失移植物丢失和死亡率相似(HR均为0.99)。

要点

  • 2014年分配政策变更后虚拟交叉配型使用率每年增加2.4%,2018年达18%。
  • 虚拟交叉配型与更短冷缺血时间相关(平均15.0 vs 16.5小时)。
  • 虚拟交叉配型与物理交叉配型的死亡删失移植物丢失和死亡率相似(HR均为0.99)。

核心结论

  • 虚拟交叉配型是缩短冷缺血时间且不负面影响移植结局的有吸引力策略。
  • 优化使用并减少实践差异可最大化虚拟交叉配型的获益。

研究设计与样本

  • 回顾性队列研究,使用美国移植受者科学登记数据。
  • 纳入2011–2018年成人 deceased donor 肾移植受者,虚拟交叉配型9,632例,物理交叉配型71,839例。

主要发现

  • 分配政策变更前仅9%移植依赖虚拟交叉配型,变更后每年增加2.4%,2018年达18%。
  • 虚拟交叉配型使用存在地区差异(范围0.7–36%),大容量中心使用率更高。
  • 与物理交叉配型相比,虚拟交叉配型与更短冷缺血时间相关(平均15.0 vs 16.5小时)。
  • 中位随访2.9年,虚拟交叉配型与物理交叉配型的死亡删失移植物丢失和死亡率相似(HR均为0.99)。

临床怎么用

  • 在 deceased donor 肾移植中可考虑采用虚拟交叉配型以缩短冷缺血时间。
  • 需关注虚拟交叉配型使用的地区与实践差异,优化其应用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

For assessing human leukocyte antigen compatibility in deceased donor kidney transplantation, virtual crossmatch is used as an alternative to physical crossmatch and has potential to reduce cold ischemia time. The 2014 United States kidney allocation system prioritized highly sensitized candidates but led to increased shipping of kidneys. Using data from the Scientific Registry of Transplant Recipients, we evaluated changes in virtual crossmatch use with the new allocation policy and the impact of virtual crossmatch use on cold ischemia time and transplant outcomes. This was a retrospective cohort study of adult deceased donor kidney recipients in the United States (2011-2018) transplanted with either 9,632 virtual or 71,839 physical crossmatches. Before allocation change, only 9% of transplants were performed relying on a virtual crossmatch. After the 2014 allocation change, this increased by 2.4%/year so that 18% transplants in 2018 were performed with just a virtual crossmatch. There was significant variation in virtual crossmatch use among transplant regions (range 0.7-36%) and higher use was noted among large volume centers. Compared to physical crossmatches, virtual crossmatches were significantly associated with shorter cold ischemia times (mean 15.0 vs 16.5 hours) and similar death-censored graft loss and mortality (both hazard ratios HR 0.99) at a median follow-up of 2.9 years. Thus, our results show that virtual crossmatch is an attractive strategy for shortening cold ischemia time without negatively impacting transplant outcomes. Hence, strategies to optimize use and reduce practice variation may allow for maximizing benefits from virtual crossmatch.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Puttarajappa CM, Jorgensen D, Yabes JG, et al. Trends and impact on cold ischemia time and clinical outcomes using virtual crossmatch for deceased donor kidney transplantation in the United States. Kidney Int. 2021. PMID: 33940109. doi:10.1016/j.kint.2021.04.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。